Home›Stock Screener›Zydus Life Science›Quarterly Results

Zydus Life Science Quarterly Results

Latest Quarter Net Profit
₹1,341 Cr
QMar 2026
Quarterly Results

Zydus Life Science quarterly results. In Mar 2026, Zydus Life Science (ZYDUSLIFE) reported revenue ₹7,569 Cr and net profit ₹1,341 Cr — revenue +18.8% YoY. Review ZYDUSLIFE price earnings ratio to evaluate earnings-based valuation against sector peers.

ZYDUSLIFE Quarterly Results — Revenue, Profit & EPS Highlights

Zydus Life Science latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check ZYDUSLIFE company valuation to track the company's total market size over time.

  • Revenue of ₹7,569 Cr in Mar 2026 (-4.3% vs Jun 2026, +18.8% vs Mar 2025)
  • Net Profit of ₹1,341 Cr in Mar 2026 (+35.5% vs Jun 2026, +7.8% vs Mar 2025)
  • EBITDA of ₹2,139 Cr in Mar 2026 (+18.7% vs Jun 2026)
  • Operating Margin of 27.0% in Mar 2026 (+5.0pp vs Jun 2026)
  • Earnings Per Share of ₹12.65 in Mar 2026 (+35.3% vs Jun 2026)

Zydus Life Science Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ZYDUSLIFE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 7,569 7,908 6,147 6,371 6,622 -4.3% 18.8%
Net Profit (₹ Cr) 1,341 990 1,239 1,244 1,521 - -
EBITDA (₹ Cr) 2,139 1,802 2,005 1,749 2,137 - -
EPS (₹) 12.65 9.35 12.51 11.64 14.58 - -
Operating Margin (%) 27.0% 22.0% 31.0% 27.0% 31.0% - -

ZYDUSLIFE Share Price Trend — 1-Year Movement Across Quarterly Results

Zydus Life Science 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Zydus Life Science screener.

Profitability Ratios

Profit Margin 17.7%
EBITDA Margin 28.3%
Operating Margin 27.0%
ROE (Annual) 18.1%

Balance Sheet Highlights

Total Assets ₹52,407 Cr
Total Equity ₹29,582 Cr
Current Assets ₹ Cr
Current Liabilities ₹7,113 Cr

Cash Flow Analysis

Operating Cash Flow ₹2,117 Cr
Investing Cash Flow ₹-7,895 Cr
Financing Cash Flow ₹5,807 Cr
Net Cash Flow ₹28 Cr

Current Market Data

Current Price ₹1135.00
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 6,371
Sept 2025 6,147
Jun 2026 7,908
Mar 2026 7,569

Net Profit Trend (₹ Cr)

Mar 2025 1,244
Sept 2025 1,239
Jun 2026 990
Mar 2026 1,341

Operating Margin Trend (%)

Mar 2025 27.0%
Sept 2025 31.0%
Jun 2026 22.0%
Mar 2026 27.0%

ZYDUSLIFE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Zydus Life Science latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1758.0 15,018 2,710 -5.6% - 18.0% 155.6
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 9162.0 2,986 751 -5.0% - 25.2% 323.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Cipla
Mar 2026 		₹106,152.60 Cr 1330.9 6,612 543 -9.3% - 8.2% 193.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores